LOGO
LOGO

AngioDynamics Sets Sights On Profitable Growth — Is It Time To Watch The Stock?

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

AngioDynamics Inc. (ANGO), a medical technology company that has undergone a strategic transformation in recent years to streamline its business and focus on high-growth MedTech markets, is now aiming to deliver sustainable, profitable growth.

The company designs, manufactures, and sells a wide range of medical, surgical, and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The devices are generally used in minimally invasive, image-guided procedures. It operates through two segments, Med Tech and Med Device.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.

RELATED NEWS